世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000034621

女性不妊症治療薬の世界市場規模調査・予測:治療薬別、投与経路別、流通チャネル別、地域別の分析(2022年〜2029年)

Bizwit Research & Consulting LLP

Global Female Infertility Treatment Drugs Market Size study & Forecast, by Therapy( Gonadotropins, Clomiphene, Letrozole, Metformin , Leuprolide Acetate and Others) by Route of Administration( Oral and Injectable), by Distribution Channel ( Hospitals Pharmacies, Retail Pharmacies and Online Pharmacies) and Regional Analysis, 2022-2029

発刊日 2023/03/06

言語英語

体裁PDF/200ページ

ライセンス/価格200ページ

0000034621

Single
Enterprise (Global Site)

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

女性不妊症治療薬の世界市場は、2021年に約26億4,980万米ドルとなり、予測期間の2022年から2029年には4.3%以上の健全な成長率で成長すると予測されています。

女性不妊症とは、女性が妊娠できない状態のことです。女性不妊症は、年齢、ホルモンバランスの乱れ、身体の健康状態、ライフスタイルの選択など、いくつかの変数によって引き起こされることがあります。女性不妊症の特定に用いられる検査には、卵巣予備能検査、子宮卵管造影検査、排卵検査などがあります。女性不妊症治療薬市場は、世界の不妊率の増加や不妊研究開発への資金提供の増加などの要因によって拡大しています。しかし、薬物療法に代わる効果的な治療法の存在や薬価の高さが、市場成長の妨げとなる可能性があります。

世界の不妊率の低下は、市場成長を促進する要因となっています。例えば、世界銀行機構によると、2017年の合計特殊出生率(女性1人当たりの出生数)は2.427であり、さらに2019年には世界全体で2.402に減少しています。したがって、これらの減少は、市場成長の原動力となっている不妊率の上昇を示すものです。さらに、世界各国の新興国市場が、治療に保険を適用することで不妊患者を支援し、医薬品開発活動が活発化していることが、市場に有利な成長をもたらしています。

女性不妊症治療薬の世界市場の調査対象地域は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域です。北アメリカは、ブランド製品の優位性とこの地域の不妊率の増加により、売上高で市場を独占しています。一方、アジア太平洋地域は、対象人口の増加、医薬品開発のための共同研究の増加、主要企業の地域的拡大、政府機関や非営利団体の市場参入などの要因により、予測期間中に最も高いCAGRで成長すると予想されます。

  • 主要企業
    ➣ Ferring Pharmaceuticals
    ➣ Merck & Co, Inc.
    ➣ Bayer AG
    ➣ Abbott Laboratories
    ➣ Par Pharmaceuticals
    ➣ Sumitovant
    ➣ Livzon
    ➣ Zydus Cadila
    ➣ Mankind Pharma
    ➣ Oxolife
  • 調査対象年
    ➣ 実績データ - 2019 - 2020 - 2021年
    ➣ 基準年 - 2021年
    ➣ 予測期間 - 2022 - 2029年

本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。

さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。

  • 市場セグメント・サブセグメント
    ➣ 治療薬別
      ◇ ゴナドトロピン
      ◇ クロミフェン
      ◇ レトロゾール
      ◇ メトホルミン
      ◇ リュープロリド酢酸塩
      ◇ その他
    ➣ 投与経路別
      ◇ 経口
      ◇ 注射剤
    ➣ 流通チャネル別
      ◇ 病院薬局
      ◇ 小売薬局
      ◇ オンライン薬局
    ➣ 地域別
      ◇ 北アメリカ
       ✓ アメリカ
       ✓ カナダ
      ◇ ヨーロッパ
       ✓ イギリス
       ✓ ドイツ
       ✓ フランス
       ✓ スペイン
       ✓ イタリア
       ✓ その他のヨーロッパ
      ◇ アジア太平洋地域
       ✓ 中国
       ✓ インド
       ✓ 日本
       ✓ オーストラリア
       ✓ 韓国
       ✓ その他のAPAC
      ◇ ラテンアメリカ
       ✓ ブラジル
       ✓ メキシコ
       ✓ その他のラテンアメリカ
      ◇ 世界のその他の地域

レポート詳細

目次

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Female Infertility Treatment Drugs Market, by Region, 2019-2029 (USD Million)
1.2.2. Female Infertility Treatment Drugs Market, by Therapy, 2019-2029 (USD Million)
1.2.3. Female Infertility Treatment Drugs Market, by Route of Administration, 2019-2029 (USD Million)
1.2.4. Female Infertility Treatment Drugs Market, by Distribution Channel, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Female Infertility Treatment Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Female Infertility Treatment Drugs Market Dynamics
3.1. Female Infertility Treatment Drugs Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing infertility rates globally
3.1.1.2. Increasing funding for infertility R&D
3.1.2. Market Challenges
3.1.2.1. The presence of effective alternatives to medications
3.1.2.2. High cost of Drugs
3.1.3. Market Opportunities
3.1.3.1. Governments worldwide to support to infertility patients by providing insurance coverage for treatment.
3.1.3.2. Rise in drug development activities

Chapter 4. Global Female Infertility Treatment Drugs Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Female Infertility Treatment Drugs Market, by Therapy
6.1. Market Snapshot
6.2. Global Female Infertility Treatment Drugs Market by Therapy, Performance - Potential Analysis
6.3. Global Female Infertility Treatment Drugs Market Estimates & Forecasts by Therapy 2019-2029 (USD Million)
6.4. Female Infertility Treatment Drugs Market, Sub Segment Analysis
6.4.1. Gonadotropins
6.4.2. Clomiphene
6.4.3. Letrozole
6.4.4. Metformin
6.4.5. Leuprolide Acetate
6.4.6. Others

Chapter 7. Global Female Infertility Treatment Drugs Market, by Route of Administration
7.1. Market Snapshot
7.2. Global Female Infertility Treatment Drugs Market by Route of Administration, Performance - Potential Analysis
7.3. Global Female Infertility Treatment Drugs Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Million)
7.4. Female Infertility Treatment Drugs Market, Sub Segment Analysis
7.4.1. Oral
7.4.2. Injectable

Chapter 8. Global Female Infertility Treatment Drugs Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Female Infertility Treatment Drugs Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Female Infertility Treatment Drugs Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Million)
8.4. Female Infertility Treatment Drugs Market, Sub Segment Analysis
8.4.1. Hospitals Pharmacies
8.4.2. Retail Pharmacies
8.4.3. Online Pharmacies

Chapter 9. Global Female Infertility Treatment Drugs Market, Regional Analysis
9.1. Female Infertility Treatment Drugs Market, Regional Market Snapshot
9.2. North America Female Infertility Treatment Drugs Market
9.2.1. U.S. Female Infertility Treatment Drugs Market
9.2.1.1. Therapy breakdown estimates & forecasts, 2019-2029
9.2.1.2. Route of Administration breakdown estimates & forecasts, 2019-2029
9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Female Infertility Treatment Drugs Market
9.3. Europe Female Infertility Treatment Drugs Market Snapshot
9.3.1. U.K. Female Infertility Treatment Drugs Market
9.3.2. Germany Female Infertility Treatment Drugs Market
9.3.3. France Female Infertility Treatment Drugs Market
9.3.4. Spain Female Infertility Treatment Drugs Market
9.3.5. Italy Female Infertility Treatment Drugs Market
9.3.6. Rest of Europe Female Infertility Treatment Drugs Market
9.4. Asia-Pacific Female Infertility Treatment Drugs Market Snapshot
9.4.1. China Female Infertility Treatment Drugs Market
9.4.2. India Female Infertility Treatment Drugs Market
9.4.3. Japan Female Infertility Treatment Drugs Market
9.4.4. Australia Female Infertility Treatment Drugs Market
9.4.5. South Korea Female Infertility Treatment Drugs Market
9.4.6. Rest of Asia Pacific Female Infertility Treatment Drugs Market
9.5. Latin America Female Infertility Treatment Drugs Market Snapshot
9.5.1. Brazil Female Infertility Treatment Drugs Market
9.5.2. Mexico Female Infertility Treatment Drugs Market
9.5.3. Rest of Latin America Female Infertility Treatment Drugs Market
9.6. Rest of The World Female Infertility Treatment Drugs Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Ferring Pharmaceuticals
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Merck & Co, Inc.
10.2.3. Bayer AG
10.2.4. Abbott Laboratories
10.2.5. Par Pharmaceuticals
10.2.6. Sumitovant
10.2.7. Livzon
10.2.8. Zydus Cadila
10.2.9. Mankind Pharma
10.2.10. Oxolife

Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

LIST OF TABLES
TABLE 1. Global Female Infertility Treatment Drugs Market, report scope
TABLE 2. Global Female Infertility Treatment Drugs Market estimates & forecasts by Region 2019-2029 (USD Million)
TABLE 3. Global Female Infertility Treatment Drugs Market estimates & forecasts by Therapy 2019-2029 (USD Million)
TABLE 4. Global Female Infertility Treatment Drugs Market estimates & forecasts by Route of Administration 2019-2029 (USD Million)
TABLE 5. Global Female Infertility Treatment Drugs Market estimates & forecasts by Distribution Channel 2019-2029 (USD Million)
TABLE 6. Global Female Infertility Treatment Drugs Market estimates & forecasts by xyz 2019-2029 (USD Million)
TABLE 7. Global Female Infertility Treatment Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 8. Global Female Infertility Treatment Drugs Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 9. Global Female Infertility Treatment Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 10. Global Female Infertility Treatment Drugs Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 11. Global Female Infertility Treatment Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 12. Global Female Infertility Treatment Drugs Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 13. Global Female Infertility Treatment Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 14. Global Female Infertility Treatment Drugs Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 15. Global Female Infertility Treatment Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 16. Global Female Infertility Treatment Drugs Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 17. U.S. Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 18. U.S. Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 19. U.S. Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 20. Canada Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 21. Canada Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 22. Canada Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 23. UK Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 24. UK Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 25. UK Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 26. Germany Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 27. Germany Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 28. Germany Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 29. France Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 30. France Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 31. France Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 32. Italy Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 33. Italy Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 34. Italy Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 35. Spain Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 36. Spain Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 37. Spain Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 38. RoE Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 39. RoE Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 40. RoE Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 41. China Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 42. China Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 43. China Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 44. India Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 45. India Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 46. India Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 47. Japan Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 48. Japan Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 49. Japan Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 50. South Korea Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 51. South Korea Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 52. South Korea Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 53. Australia Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 54. Australia Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 55. Australia Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 56. RoAPAC Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 57. RoAPAC Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 58. RoAPAC Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 59. Brazil Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 60. Brazil Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 61. Brazil Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 62. Mexico Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 63. Mexico Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 64. Mexico Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 65. RoLA Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 66. RoLA Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 67. RoLA Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 68. Row Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 69. Row Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 70. Row Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 71. List of secondary sources, used in the study of global Female Infertility Treatment Drugs Market
TABLE 72. List of primary sources, used in the study of global Female Infertility Treatment Drugs Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES
FIG 1. Global Female Infertility Treatment Drugs Market, research methodology
FIG 2. Global Female Infertility Treatment Drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Female Infertility Treatment Drugs Market, key trends 2021
FIG 5. Global Female Infertility Treatment Drugs Market, growth prospects 2022-2029
FIG 6. Global Female Infertility Treatment Drugs Market, porters 5 force model
FIG 7. Global Female Infertility Treatment Drugs Market, pest analysis
FIG 8. Global Female Infertility Treatment Drugs Market, value chain analysis
FIG 9. Global Female Infertility Treatment Drugs Market by segment, 2019 & 2029 (USD Million)
FIG 10. Global Female Infertility Treatment Drugs Market by segment, 2019 & 2029 (USD Million)
FIG 11. Global Female Infertility Treatment Drugs Market by segment, 2019 & 2029 (USD Million)
FIG 12. Global Female Infertility Treatment Drugs Market by segment, 2019 & 2029 (USD Million)
FIG 13. Global Female Infertility Treatment Drugs Market by segment, 2019 & 2029 (USD Million)
FIG 14. Global Female Infertility Treatment Drugs Market, regional snapshot 2019 & 2029
FIG 15. North America Female Infertility Treatment Drugs Market 2019 & 2029 (USD Million)
FIG 16. Europe Female Infertility Treatment Drugs Market 2019 & 2029 (USD Million)
FIG 17. Asia pacific Female Infertility Treatment Drugs Market 2019 & 2029 (USD Million)
FIG 18. Latin America Female Infertility Treatment Drugs Market 2019 & 2029 (USD Million)
FIG 19. Global Female Infertility Treatment Drugs Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

この商品のレポートナンバー

0000034621

TOP